Compounds > naxagolide
Page last updated: 2024-08-24

naxagolide and bromocriptine

naxagolide has been researched along with bromocriptine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diederich, NJ; Goetz, CG1
Login, IS; Trugman, JM1
Arnold, WS; Touchet, N; Trugman, JM; Wooten, GF1
Bankiewicz, KS; Belluzzi, JD; Domino, EF; May, JM; McAfee, DA1

Reviews

1 review(s) available for naxagolide and bromocriptine

ArticleYear
Dopaminergic agonists in the treatment of Parkinson's disease.
    Neurologic clinics, 1992, Volume: 10, Issue:2

    Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine

1992

Other Studies

3 other study(ies) available for naxagolide and bromocriptine

ArticleYear
The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells.
    Neuropharmacology, 1989, Volume: 28, Issue:6

    Topics: Angiotensin II; Animals; Bromocriptine; Colforsin; Cyclic AMP; Dopamine Antagonists; Female; Haloperidol; In Vitro Techniques; Oxazines; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone

1989
D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 250, Issue:3

    Topics: Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Bromocriptine; Deoxyglucose; Glucose; Male; Oxazines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Substantia Nigra

1989
N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromocriptine; Disease Models, Animal; Dominance, Cerebral; Dopamine Agents; Female; Injections, Intramuscular; Macaca nemestrina; Male; Oxazines; Oxidopamine; Parkinson Disease, Secondary; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior; Substantia Nigra; Tetrahydronaphthalenes; Thiophenes

1994